Anjali Sharma1, Peter L Flom, Jeremy Weedon, Robert S Klein. 1. Department of Medicine, Division of Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA. anjali.sharma@downstate.edu
Abstract
OBJECTIVE: To investigate rates and predictors of change in bone mineral density (BMD) in a cohort of aging men with or at risk for HIV infection. DESIGN: A prospective cohort study among 230 HIV-infected and 159 HIV-uninfected men aged at least 49 years. METHODS: Longitudinal analyses of annual change in BMD at the femoral neck, total hip, and lumbar spine. RESULTS: At baseline, 46% of men had normal BMD, 42% had osteopenia, and 12% had osteoporosis. Of those men with normal BMD, 14% progressed to osteopenia and 86% continued to have normal BMD. Of the men initially with osteopenia, 12% progressed to osteoporosis and 83% continued to have osteopenia. Osteopenia incidence per 100 person-years at risk was 2.6 for HIV-uninfected men and 7.2 for HIV-infected men; osteoporosis incidence was 2.2 per 100 person-years at risk among men with osteopenia, regardless of HIV status. In multivariable analysis of annual change in BMD at the femoral neck, we found a significant interaction between heroin use and AIDS diagnosis, such that the greatest bone loss occurred with both AIDS and heroin use (adjusted predicted mean annual bone loss 0.0196 g/cm). Hepatitis C virus seropositivity was also associated with femoral neck bone loss (P = 0.04). The interaction between AIDS and heroin use also was associated with bone loss at the total hip, as was current methadone use (P < 0.01). CONCLUSION: We found an association of heroin use and AIDS with BMD change, suggesting that heroin users with AIDS may be at particular risk for bone loss.
OBJECTIVE: To investigate rates and predictors of change in bone mineral density (BMD) in a cohort of aging men with or at risk for HIV infection. DESIGN: A prospective cohort study among 230 HIV-infected and 159 HIV-uninfectedmen aged at least 49 years. METHODS: Longitudinal analyses of annual change in BMD at the femoral neck, total hip, and lumbar spine. RESULTS: At baseline, 46% of men had normal BMD, 42% had osteopenia, and 12% had osteoporosis. Of those men with normal BMD, 14% progressed to osteopenia and 86% continued to have normal BMD. Of the men initially with osteopenia, 12% progressed to osteoporosis and 83% continued to have osteopenia. Osteopenia incidence per 100 person-years at risk was 2.6 for HIV-uninfectedmen and 7.2 for HIV-infectedmen; osteoporosis incidence was 2.2 per 100 person-years at risk among men with osteopenia, regardless of HIV status. In multivariable analysis of annual change in BMD at the femoral neck, we found a significant interaction between heroin use and AIDS diagnosis, such that the greatest bone loss occurred with both AIDS and heroin use (adjusted predicted mean annual bone loss 0.0196 g/cm). Hepatitis C virus seropositivity was also associated with femoral neck bone loss (P = 0.04). The interaction between AIDS and heroin use also was associated with bone loss at the total hip, as was current methadone use (P < 0.01). CONCLUSION: We found an association of heroin use and AIDS with BMD change, suggesting that heroin users with AIDS may be at particular risk for bone loss.
Authors: D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage Journal: Am J Epidemiol Date: 2000-07-15 Impact factor: 4.897
Authors: M Pedrazzoni; P P Vescovi; L Maninetti; M Michelini; G Zaniboni; G Pioli; D Costi; F S Alfano; M Passeri Journal: Acta Endocrinol (Copenh) Date: 1993-07
Authors: Kathleen Mulligan; David V Glidden; Peter L Anderson; Albert Liu; Vanessa McMahan; Pedro Gonzales; Maria Esther Ramirez-Cardich; Sirianong Namwongprom; Piotr Chodacki; Laura Maria Carvalo de Mendonca; Furong Wang; Javier R Lama; Suwat Chariyalertsak; Juan Vicente Guanira; Susan Buchbinder; Linda-Gail Bekker; Mauro Schechter; Valdilea G Veloso; Robert M Grant Journal: Clin Infect Dis Date: 2015-04-23 Impact factor: 9.079
Authors: Richard Saitz; Aldina Mesic; Alicia S Ventura; Michael R Winter; Timothy C Heeren; Meg M Sullivan; Alexander Y Walley; Gregory J Patts; Seville M Meli; Michael F Holick; Theresa W Kim; Kendall J Bryant; Jeffrey H Samet Journal: Alcohol Clin Exp Res Date: 2018-06-06 Impact factor: 3.455
Authors: J Pepe; A M Isidori; M Falciano; G Iaiani; A Salotti; D Diacinti; R Del Fiacco; E Sbardella; C Cipriani; S Piemonte; O Raimo; P Biondi; F Biamonte; A Lenzi; S Minisola Journal: Endocrine Date: 2014-08-08 Impact factor: 3.633
Authors: Suman Srinivasa; Kathleen V Fitch; Eva Petrow; Tricia H Burdo; Kenneth C Williams; Janet Lo; Hélène C F Cȏté; Steven K Grinspoon Journal: J Acquir Immune Defic Syndr Date: 2014-12-01 Impact factor: 3.731